Objective To study the outcome of pregnancy with systemic lupus erythematosus (SLE) treated by DNA immunoabsorbent therapy Methods Sixty nine SLE women with pregnancy were randomly enrolled into DNA immunoabsorbent group (35, group Ⅰ) and common therapeutic group (34, group Ⅱ) as control Outcomes of pregnancy and complications were analyzed Results The incidence of complication and fetus loss in group Ⅰ was 28 6% (10 cases) and 20 0% (7 cases), while 85 3% (29 cases) and 58 8% (20 cases) in gro...